PFE-US Reports Q2 Earnings and Revenue Surpass Expectations, Upgrades Full-Year EPS Guidance
A financial news app has learned that Pfizer (PFE.US) announced its second-quarter earnings on Tuesday, benefiting from strong demand for heart disease medication Vyndaqel and blood thinner Eliquis. T